In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other stocks. Ken Fisher is the founder and executive chairman of Fisher Asset Management ...

Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 18 unusual trades. Delving into the details, we found 33 ...

A Novo Nordisk completou com sucesso o teste clínico de uma injeção experimental para perda de peso, anunciou a empresa nesta sexta-feira, 24, em comunicado. O medicamento mostrou que os ...

Novo Nordisk’s annual results are out and they show the Danish pharmaceutical juggernaut earnt 290.4 billion Danish kroner last year (A$64 billion) — up 25%. Novo Nordisk boasts 45 million ...

Less-than-stellar phase 3 results with Novo Nordisk's highly anticipated obesity therapy CagriSema have caused its shares to fall by over a fifth, wiping around $94 billion off its market cap.

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent as it tries to meet surging demand for its diabetes ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Além de disputar espaço com os SUVs compactos no Brasil, a Nissan planeja exportar o novo modelo para até 20 países da América Latina, ampliando sua presença na região. Esse movimento faz ...

Um novo remédio para o tratamento da dor aguda, aprovado recentemente pelo FDA, órgão regulador de medicamentos nos EUA, promete se tornar um instrumento importante na luta contra a crise dos ...

Some lawmakers even called on the FDA to probe the commercial. Novo Nordisk, maker of branded GLP-1 treatments, has now countered with an ad of its own. The ad, placed in major newspapers ...